John Wilinsky, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 31 Hall Dr, Amherst, MA 01002 Phone: 413-256-4396 |
News Archive
Hospital bereavement services that are led by senior doctors and nurses and the person responsible for quality and safety may help to curb patient complaints and legal action in the wake of a difficult death, suggest the results of a pilot study, carried out at one NHS hospital trust and published online in the journal BMJ Supportive & Palliative Care.
Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's Erythromycin Ophthalmic Ointment USP 1 g as a supplement to the Company's already approved Abbreviated New Drug Application (ANDA) for Erythromycin Ophthalmic Ointment USP 3.5 g. The company has begun shipping the product to its customers.
BD (Becton, Dickinson and Company) has voluntarily executed a product recall of certain lots of BD Q-Syte™ Luer Access Devices and BD Nexiva™ Closed IV Catheter Systems. Use of the affected devices may cause an air embolism or leakage of blood and/or therapy, which may result in serious injury or death. This field corrective action included notification to customers worldwide by letter. Neither the costs anticipated with the recall, nor the impact on BD's business, are expected to be material.
The Economist reports on a demonstration by about 300 people living with HIV and activists outside the headquarters of China's Henan provincial government in Zhengzhou on August 27.
As Japan still reels with the after effects of the March 11 earthquake and tsunami, and radiation exposure, plant workers are working to control the radiation leakage from the Fukushima Daiichi complex. Experts note that the work there will take years, posing a risk of accidental exposure.
› Verified 1 days ago